Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Relais Group Plc: Share Repurchase 14.8.2024

Relais Group Plc  ANNOUNCEMENT  14.8.2024 Relais Group Plc: Share Repurchase 14.8.2024 In the Helsinki Stock Exchange Trade date           14.8.2024Bourse trade         BuyShare                  RELAISAmount             470 SharesAverage price/ share    13,5500 EURTotal cost            6 368,50 EUR Relais Group Plc now holds a total of 43 699 sharesincluding the shares repurchased on 14.8.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

#24-282 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

SOFTSWISS Poised to Become First Certified Software Provider in Brazil

SOFTSWISS, a global leader in the iGaming technology with over 15 years of experience, is on track to secure certification for its Casino Platform and Sportsbook in Brazil. The certification process, conducted by an authorised testing laboratory, is currently underway. As the process unfolds, SOFTSWISS shares insights into the critical requirements for success in the burgeoning Brazilian market.Last year, SOFTSWISS obtained GLI-19 and GLI-33 certifications ,

Genexis celebrates successful first year of North American expansion at FiberConnect 2024

Genexis, a leading provider of cutting-edge fiber-to-the-home (FTTH) and broadband solutions for the in-home network experience, is excited to announce its participation in FiberConnect 2024.Genexis’ attendance marks its first year in the North American market, with significant milestones, including four strategic partnerships, establishing a company entity, and achieving FCC certification. Delivery of first direct project Genexis' official North American market launch was at FiberConnect 2023. Since then, the company has won and delivered its first direct project, Williamstown,

Borr Drilling Limited – 2024 AGM Results Notification

Borr Drilling Limited (the “Company”) advises that the 2024 Annual General Meeting of the Company was held on August 14, 2024 at 10:00 ADT at 2[nd] Floor, The S.E. Pearman Building, 9 Par-la-Ville Road, Hamilton HM 11, Bermuda.  The audited consolidated financial statements for the Company for the year ended December 31, 2023 were presented to the Meeting. The following resolutions were passed: 1. To set the maximum number of Directors of the Company to be not more than seven. 2. To re-elect Tor Olav Trøim as a Director of the Company. 3. To re-elect Alexandra Kate Blankenship as

Medical simulation company moves HQ to Gothenburg

Norwegian technology startup Skillup is relocating its operations to Gothenburg. The region’s capabilities within medical simulation, its strong startup infrastructure and the ability to attract international investments were a few of the reasons behind the move.The company, which is registered in Sweden as Simlogic AB, specialises in the use of virtual reality (VR) and gaming technology for medical simulation. “There is a lack of sufficient practice time for clinicians to develop and practice emergency medical competencies and clinical decision-making skills. While conventional

Read original

Genexis partners with Titan Telecom International to expand North American market

Genexis, a leading provider of cutting-edge fiber-to-the-home (FTTH) and broadband solutions for the home, is thrilled to announce a new partnership with Titan Telecom International, a U.S. supplier of premium networking equipment.This collaboration marks the expansion of Genexis' footprint in North America, aiming to bring advanced and sustainable broadband solutions to everyone’s home. "Partnering with Titan Telecom International is a crucial step in our North American expansion strategy. Titan's dedication to quality and exceptional service aligns perfectly with us, and together, we

Dicot Pharma AB publishes prospectus in connection with the upcoming rights issue

Uppsala, Sweden, August 14, 2024. The Board of Directors of Dicot Pharma AB today publishes an EU growth prospectus (the "Prospectus") in relation to the rights issue of units consisting of shares and warrants of series TO6 resolved by the Board of Directors on August 7, 2024 (the "Rights Issue"). The prospectus has today been approved and registered by the Swedish Financial Supervisory Authority.NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH

Find the Best Low Deposit Casinos with CasinoRank's Expert Reviews

Explore $1, $2, $3, $5, and $10 Deposit Casinos with Exclusive Bonuses and In-Depth Reviews CasinoRank, a leading authority in the online gambling industry, is thrilled to announce the launch of its expert guides on low minimum deposit casinos. These guides help players discover the best online, live, and mobile casinos that accept deposits as low as $1, $2, $3, $5, and $10, complete with detailed reviews and exclusive bonusesAffordable Gaming Options for Every Player The new series addresses the increasing demand for affordable gaming options, providing players with valuable

MAGic™ BioProcessing Announces Changes to Board of Directors

Uppsala, Sweden - August 14, 2024 – MAGic BioProcessing is pleased to announce the appointment of Günter Jagschies new board member while also acknowledging the departure of our valued board member Kristina Köhler. These changes mark an important step in the company's ongoing commitment to excellence and strategic growth. Dr. Jagschies brings a wealth of experience and expertise in the bioprocessing field, having held key positions at GE Healthcare Life Sciences, now known as Cytiva. His extensive background and knowledge will be invaluable as MAGic Bioprocessing continues to drive

International gaming company extends and expands its collaboration with Aixia for backup solution to a value of SEK 1 million

Mölndal                                                                                      2024-08-14 Aixia announces that a major international gaming company has extended and expanded its partnership with us. The new business, which is worth SEK 1 million, involves an upgrade of their existing backup solution. The expansion is proof of the trust and satisfaction the customer feels for Aixia's services. Our long-term collaboration has developed into a partnership where we continuously contribute to ensuring the customer's data protection and business continuity. By choosing to

Interim Report April–June 2024: Improved quarterly results but with continued challenges

For the first half of the year LKAB’s net sales and operating profit both decreased as a consequence of missed deliveries at the beginning of the year. In terms of the second quarter, however, operating profit increased to MSEK 2,666 (2,257) as parts of accumulated inventories were delivered.Net sales for the second quarter amounted to MSEK 9,851 (9,350). The increase is mainly due to higher deliveries and a somewhat weaker Swedish krona. Operating profit amounted to MSEK 2,666 (2,257) and was also affected by insurance payouts received during the quarter as compensation for missed

Invitation to presentation of second quarter and half year result 2024

Multiconsult (OSE: MULTI) second and half year results 2024 will be released on Wednesday 21 August at 07:00 CET. Multiconsult hereby invites you to the presentation of the results and participants are invited to attend.The Norwegian presentation will be held at Hotel Continental, Stortingsgata 24/26, Oslo, at 08:30. The presentations will be held by Grethe Bergly (CEO) and Ove B. Haupberg (CFO). The results will also be presented through live webcasts: In Norwegian at 08:30 and in English at 09:30. Participants will have the opportunity to submit questions online throughout the webcast

PhII preliminary results from skin cancer clinical trial show an 86%overall reduction of tumor size, complete clearance in 51%of the patients and the potential to be utilized as a first-line therapy

Oslo, 14 August 2024. Lytix Biopharma (“Lytix”) announces that its Nasdaq-listed licensing partner Verrica Pharmaceuticals reports positive top-line Phase II results from its study in patients with basal cell carcinoma (BCC) - the largest skin cancer disease globally with a projected global market size of USD 11.5 bn in 2028 (CAGR 7.9%) and 3.6 million new cases in the US annually [1].    The study investigates Lytix’s lead drug candidate LTX-315 in BCC patients and shows impressively an: · 86 percent overall reduction of tumor size · 51 percent complete clearance rate of

Implantica presents the second quarter 2024 on August 21 at 15:00 CEST

Implantica AG (publ) invites investors to a presentation of the second quarter 2024 at 15:00 CEST on August 21. The interim report for the second quarter will be published at 8:00 a.m. CEST on the same day.The presentation will be in English via an audiocast with teleconference: If you wish to participate via webcast, please use the following link: · https://ir.financialhearings.com/implantica-q2-report-2024 If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the

Axentia Group AB (publ) appoints new CFO

Axentia Group AB (publ) ("Axentia" or the "Company") appoints Johanna Klint as new Chief Financial Officer (CFO) as of September 1, 2024. Johanna Klint will also take on the role of CFO of the parent company Axentia Group Holding AB. As part of the Company's continued expansion, the management team will be strengthened through the appointment of a new CFO with broad experience from both private and listed companies. Johanna Klint comes from a previous position as CFO and Group Management Member at Vectura Fastigheter AB. Johanna also has extensive experience as an Investment Manager at

Metsä Group's Kerto LVL mill in Äänekoski reached its rooftop height

Metsä Group's Kerto LVL mill project is progressing as planned in Äänekoski, Finland, and the mill has reached its rooftop height. The mill's topping out ceremony was held today on Wednesday 14 August 2024. Topping out ceremony is a traditional event that is celebrated when the ceilings are ready and buildings are at the rooftop height. Metsä Wood’s Executive Vice President Jaakko Anttila, Metsä Wood’s Project Director Eero Lampola, and SRV’s Chief Executive Officer Saku Sipola gave their greetings at the event. The construction work will be completed in the autumn of 2025 and production at

Anand Patel new Chief Financial Officer of Medicover

Medicover AB (publ) has signed a letter of intent with Anand Patel to join Medicover as the Chief Financial Officer (CFO) and member of the Executive Management Team. Anand will join Medicover from October 1, 2024, with the handover of the role during Q4 2024. Anand Patel has developed his career in the retail sector, where he has held international finance and business management positions and has extensive experience from Polish and Central- East Europe markets. He has served as the CFO and managing director of Pepco, a rapidly expanding international retail chain – one of the leading

Webstep ASA: Eva Johannesdottir new general manager of Webstep Stavanger

Oslo, 14 August 2024: Webstep has appointed Eva Johannesdottir as new General Manager of the Stavanger office.Johannesdottir comes from the position as a Business Unit Manager at Bouvet, and will take on the position from 1. September 2024. "I'm really looking forward to welcoming Eva Johannesdottir to Webstep. She is a recognized culture builder with an impressive growth and performance oriented track record, which is a perfect fit for Webstep going forward,” said Kristine Lund, CEO of Webstep. Eva Johannesdottir has more than 15 years of experience from IT-consultancy and management,

Audientes A/S Signs Definitive Agreement with Shenzhen Hengtong Partner Co. Ltd. to Establish Joint Venture

Company announcement no. 27-2024August 14, 2024 Today, Audientes A/S of Denmark and Shenzhen Hengtong Partner Co. Ltd. of China have signed a definitive agreement to establish a Joint Venture company in the Hearing Industry.Audientes A/S (“Audientes”), CVR 36047631, a Danish innovator in the field of affordable, self-fitting hearing aids and hearables, and Shenzhen Hengtong Partner Co. Ltd. (“Hengtong”), investor in Audientes and distributor of its hearing products in China, are pleased to announce the signing of a definitive agreement to establish their joint venture in the hearing

Supplement to the release: Inside information: Spinnova and Valmet have signed a Partnership Agreement regarding the delivery of process equipment for Spinnova’s customers

SPINNOVA PLC, COMPANY RELEASE, INSIDE INFORMATION 14 AUGUST 2024 at 1:45 p.m. EEST  Supplement to the release: Inside information: Spinnova and Valmet have signed a Partnership Agreement regarding the delivery of process equipment for Spinnova’s customers Spinnova Plc supplements its inside information release published on 12 August 2024 at 3:15 p.m. EEST. The release is supplemented with the following information concerning the Partnership Agreement with Valmet: Spinnova Plc and Valmet have signed a strategic Partnership Agreement. The partnership agreement is valid for four

Season of birth is associated with the development of asthma and allergic rhinitis

Being born in autumn or winter is associated with asthma and allergic rhinitis in Finland, a new registry-based study shows.Season of birth, and specifically being born in autumn or winter, is associated with allergic rhinitis and asthma in Finland, a new study by the University of Eastern Finland, the University of Helsinki and Helsinki University Hospital shows. Conversely, being born in summer was associated with the lowest incidence of asthma and allergic rhinitis. “When using summer as a reference, we found that being born in any other time of the year was significantly associated

Troax Group: Interim Report January - June 2024

Hillerstorp 14[th] of August 2024, 12:30 CET APRIL – JUNE · Order intake in the quarter increased by 6 percent compared with the same period last year and amounted to 69,6 (65,4) MEUR. Adjusted for currency and acquisitions the order intake decreased by 3 percent. · Sales in the quarter increased by 5 percent compared with the same period last year and amounted to 71,9 (68,5) MEUR. Adjusted for currency and acquisitions sales decreased by 4 percent. · Operating profit before amortizations (EBITA) decreased to 12,1 (13,0) MEUR. · Operating margin before amortizations (EBITA

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 14 August 2024 at 1.30 p.m. (EEST) Sitowise Group Plc (the "Company") has on 13 August 2024 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Protector Forsikring ASA, according to which Protector Forsikring ASA's direct holding of the shares and votes of the Company increased above 5.00 percent on 13 August 2024. According to the notification, Protector Forsikring ASA holds a total of 2,454,047 shares corresponding to 6.85 percent of the Company’s shares and votes.  The Company

There are no items matching the current filter
There are no more items matching the current filter
Back to top